TASP-V (Centre Hospitalier Universitaire Vaudois)

N/A

Report date: 2022/02/18 09:59:11
NME

Base Information

Drug NameTASP-V (Centre Hospitalier Universitaire Vaudois)
Drug Alias NameTASP-V
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNeuropeptide Y receptor type 2 agonists
TargetsNeuropeptide Y receptor type 2
Therapy Area/IndicationsRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversite De Lausanne
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversite De Lausanne
Active IndicationsN/A
Inactive IndicationsRhinitis, AllergicAsthma

Other Information

ATC CodeN/A
Related LinksN/A